Perrigo Company plc (PRGO) Stock Analysis

Perrigo Company plc (PRGO) Stock Analysis — AI Research | MarketCI

PRGO

Market Closed

Perrigo Company plc

NYSEHealthcare Drug Manufacturers - Specialty & Generic

8.38K employees

CEO: Patrick Lockwood-Taylor

Founded: 1991

$10.61

+$0.00(+NaN%)

Market Cap

1.47B

Beta

0.54

52W Range

N/A

Dividend Yield

10.93%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

PRGO Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for PRGO built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Strong Sell

Pass %

28.57%

Score

2/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$235.84

AI Price Target

Machine learning • Price prediction

$9.91

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$0.00

Financial Health

Bankruptcy risk assessment

-0.25

Quality Score

Financial strength rating

4.00

AI Investment Grade

Deep analysis of filings & news

45.00

Key Investment Highlights

Important factors affecting PRGO investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

52.63% Good

Conditions Met

20.00/38.00

Due Diligence Score

52.63%

Due Diligence Conditions

Investment analysis conditions and results


	Fail
	Pass
	Pass
	Fail
	Fail
	Fail

Showing 1 to 6 of 46 conditions